Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Bioinformatics

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 201-225 out of 972.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>

Public Release: 6-Dec-2016
Cannabis and Cannabinoid Research
Do cannabis users think package warnings are needed?
Legalization of cannabis for medical or leisure use is increasing in the US, and many experts and cannabis users alike agree that package warnings stating the health risks are needed. The warnings suggested by cannabis users are not necessarily the same as those of medical experts though, as shown in a new study published in Cannabis and Cannabinoid Research.

Contact: Kathryn Ryan
kbrennan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 6-Dec-2016
Scientific Reports
Critical genes unravelled to understand human diseases and support drug discovery
A network analysis of proteins that are most important in responding to environmental signals highlights potential targets for drugs and provides better information on the genetic basis of diseases.

Contact: Hayley London
hayley.london@earlham.ac.uk
07-760-438-218
Earlham Institute

Public Release: 6-Dec-2016
Aging
GeroScope -- a computer method to beat aging
It takes decades of work and millions of dollars to develop new anti-ageing drugs. Computer modeling techniques may significantly reduce the time and cost of development. Scientists have devepoled a GeroScope algorithm to identify geroprotectors -- substances that extend healthy life. GeroScope is able to compare changes in the cells of young and old patients and search for drugs with minimal side effects. The ability to simulate biological effects with a high level of accuracy in silico is a real breakthrough.
Life Extension Foundation, Nvidia Corporation

Contact: Asya Shepunova
shepunova@phystech.edu
7-916-813-0267
Moscow Institute of Physics and Technology

Public Release: 5-Dec-2016
CSU to provide bioprocessing expertise for Department of Defense
Facilities that manufacture biologic drugs like vaccines are a critical part of the nation's biodefense infrastructure. Possible breaches of data systems controlling these biomanufacturing supply chains call for an assessment of their vulnerability to cyberattacks. Colorado State University's Jean Peccoud is part of a multi-institutional team newly commissioned to analyze the security of the nation's biomanufacturing infrastructure.
Department of Defense

Contact: Anne Manning
anne.manning@colostate.edu
970-491-7099
Colorado State University

Public Release: 5-Dec-2016
Nature Chemical Biology
Small but mighty: Tiny proteins with big roles in biology
Salk scientists discover a small protein important for cellular housekeeping.

Contact: Salk Communications
press@salk.edu
858-453-4100
Salk Institute

Public Release: 5-Dec-2016
Biodiversity Data Journal
Efficiency of insect biodiversity monitoring via Malaise trap samples and DNA barcoding
An international team of scientists evaluated the performance of DNA barcoding and the barcode reference library applied to large-scale Malaise trap samples from two German sites over the span of one summer. The scientists conclude that such approaches could help in providing crucial knowledge of the insect biodiversity and its dynamics, as well as enable more efficient management of a habitat's inventory. Their findings are published in the open access Biodiversity Data Journal.

Contact: Dr Matthias F. Geiger
m.geiger@zfmk.de
Pensoft Publishers

Public Release: 5-Dec-2016
Bioinformatics
Rapid validation for genome assemblies? Introducing KAT: K-mer Analysis Toolkit
A new bioinformatics tool has been released by the Earlham Institute that provides rapid validation for whole genome sequencing data as well as genome assemblies produced from Next Generation Sequencing (NGS) data.

Contact: Hayley London
hayley.london@tgac.ac.uk
160-345-0107
Earlham Institute

Public Release: 5-Dec-2016
Nature Communications
Wise plant analysis
Weizmann Institute's WeizMass and MatchWeiz help identify plant metabolites.

Contact: yael edelman
yael.edelman@weizmann.ac.il
Weizmann Institute of Science

Public Release: 5-Dec-2016
Novel genetic tools for bioassessment of European aquatic ecosystems, COST grant proposal
Aquatic ecosystems of our 'blue planet' are severely impacted by pollution and exploitation. Thus there is an urgent need for conservation actions in order to protect and preserve them. This is why monitoring and bioassessment are crucial. The new DNAqua-Net COST Action, funded by the European Union is set to develop new genetic tools for bioassessment and monitoring of aquatic ecosystems. The grant proposal is published in the open-access journal Research Ideas and Outcomes.
European Union

Contact: Florian Leese
florian.leese@uni-due.de
Pensoft Publishers

Public Release: 2-Dec-2016
Nature Reviews Drug Discovery
Map of drugs reveals uncharted waters in search for new treatments
Scientists have created a map of all 1,578 licensed drugs and their mechanisms of action -- as a means of identifying 'uncharted waters' in the search for future treatments. Their analysis of drugs licensed through the Food and Drug Administration reveals that 667 separate proteins in the human body have had drugs developed against them -- just an estimated 3.5 percent of the 20,000 human proteins.
The Institute of Cancer Research London

Contact: Claire Hastings
chastings@icr.ac.uk
020-715-35380
Institute of Cancer Research

Public Release: 1-Dec-2016
Cell Systems
New computational model provides a tool for improving the production of valuable drugs
The model allows scientists to make comprehensive simulations without doing tedious experiments in the laboratory. Hence, the model will tell the scientist, which metabolic pathways are involved in the production of a specific drug, and which growth conditions will presumably give the optimized production potential. This will allow researchers to design better CHO cells optimized for production of therapeutic proteins, which could result in lower prices and greater availability of many drugs.
Novo Nordisk Foundation

Contact: Nathan Lewis
n4lewis@ucsd.edu
Technical University of Denmark

Public Release: 1-Dec-2016
Cancer Letters
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
IDIBELL researchers describe the Ewing's sarcoma (ES) methylation profile for the first time. The methylation profile unveils the potential of the PTRF gene as a prognostic marker of the disease. The reestablishment of PTRF expression could serve as a therapeutic option in the future.
Carlos III Institute of Health, Asociación Española contra el Cáncer, Fundación Alba Pérez

Contact: Gemma Fornons
gfornons@idibell.cat
0034-638-685-074
IDIBELL-Bellvitge Biomedical Research Institute

Public Release: 30-Nov-2016
Information Sciences
Overlooked elements of language and literature play a key role
Everything is pointing towards success in unravelling the mysteries inherent in every human language, which for nearly 100 years have been an object of intrigue for mathematicians and linguists working on studies into statistics of literature. New analysis of the frequencies of word occurrence in the most famous works of literature, undertaken at the Institute of Nuclear Physics of the Polish Academy of Sciences in Krakow, have shown that our languages are structurally more complex and more exhaustive than they ever before seemed.

Contact: Prof. Stanislaw Drozdz
stanislaw.drozdz@ifj.edu.pl
48-126-628-220
The Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences

Public Release: 29-Nov-2016
Nucleic Acids Research
EDGE bioinformatics brings genomics to everyone
A new bioinformatics platform called Empowering the Development of Genomics Expertise (EDGE) will help democratize the genomics revolution by allowing users with limited bioinformatics expertise to quickly analyze and interpret genomic sequence data.

Contact: Nick Njegomir
njegomir@lanl.gov
505-665-9394
DOE/Los Alamos National Laboratory

Public Release: 29-Nov-2016
Genome Research
A surprizing finding shines new light on the largest group of human proteins
The study is the largest to map DNA binding sites and protein-protein interactions for C2H2-ZF proteins, the most abundant human proteins.
Canadian Institutes of Health Research, Canadian Institute for Advanced Research

Contact: Jovana Drinjakovic
jovana.drinjakovic@gmail.com
416-543-7820
University of Toronto

Public Release: 29-Nov-2016
Nature Methods
Omnipath sends strong signal
Omnipath unifies 27 data resources on biological pathways, helping scientists better understand interactions between signalling proteins. Published in Nature Methods, the Omnipath data resource and Pypath software offer an unprecedentedly clear view on signalling pathways in living systems.

Contact: Hayley London
hayley.london@earlham.ac.uk
01-603-450-107
Earlham Institute

Public Release: 29-Nov-2016
Nature Biotechnology
Digital microbes for munching yourself healthy
A research team at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg has taken an important step in modelling the complexity of the human gut's bacterial communities -- the microbiome -- on the computer. The researchers gathered all known data on the metabolism of 773 bacterial strains -- more than ever before. Working from this data, they developed a computer model for each bacterial strain.
Luxembourg National Research Fund, US Department of Energy

Contact: Thomas Klein
thomas.klein@uni.lu
352-466-644-5148
University of Luxembourg

Public Release: 28-Nov-2016
Nature Communications
Secret phenotypes: Disease devils in invisible details
The human eye often falls short in the hunt for faint genetic drivers that raise the risk of devastating neurological diseases such as autism and schizophrenia. But little eludes a microscope optic attached to a computer, and algorithms that can relate previously hidden phenotypes to subtle genetic mutations.
National Institutes of Health

Contact: Ben Brumfield
ben.brumfield@comm.gatech.edu
404-660-1408
Georgia Institute of Technology

Public Release: 25-Nov-2016
Cell Systems
Enough is enough -- stem cell factor Nanog knows when to slow down
The transcription factor Nanog plays a crucial role in the self-renewal of embryonic stem cells. Previously unclear was how its protein abundance is regulated in the cells. Researchers at the Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with colleagues from ETH Zürich, now report in Cell Systems that the more Nanog there is on hand, the less reproduction there is.

Contact: Dr. Carsten Marr
carsten.marr@helmholtz-muenchen.de
49-893-187-2158
Helmholtz Zentrum München - German Research Center for Environmental Health

Public Release: 23-Nov-2016
TGen awarded $200,000 by NVIDIA Foundation to accelerate its technology
Faster and more precise information about how best to treat cancer patients should be possible thanks to a $200,000 Compute the Cure grant announced today from the NVIDIA Foundation to the Translational Genomics Research Institute. This process will advance the practice of precision medicine by quickly informing doctors with the best options for attacking each individual patient's cancer.
NVIDIA Foundation

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 23-Nov-2016
Avian Research
Genomics reveals hen harrier is 2 distinct species
Deemed as one species spread across different continents, scientists confirm that the Eurasian hen harrier and the American Northern harrier are in fact two distinct species.

Contact: Hayley London
hayley.london@earlham.ac.uk
01-603-450-107
Earlham Institute

Public Release: 22-Nov-2016
Molecular Biology and Evolution
Diversity without limits
Now, researchers at Temple and Oakland universities have completed a new tree of prokaryotic life calibrated to time, assembled from 11,784 species of bacteria. The new tree explores grand patterns of evolutionary change that, surprisingly, has revealed remarkable similarities with that of eukaryotes, including animals, plants, and fungi.

Contact: Joseph Caspermeyer
MBEpress@gmail.com
480-258-8972
Molecular Biology and Evolution (Oxford University Press)

Public Release: 22-Nov-2016
Science Signaling
Secretion rates and amounts of insulin trigger different responses in gene expression
Japanese researchers have found that genes respond differently to the amount and rate of secretions of insulin, a hormone whose malfunction can lead to obesity and diabetes. Some genes express themselves quickly when stimulated by high levels of insulin, while others pick up on low sustained levels of the hormone, and repress themselves instead.

Contact: Kanako Takeda
kouhou@adm.s.u-tokyo.ac.jp
81-358-410-654
University of Tokyo

Public Release: 21-Nov-2016
Nature Communications
Family ties: Immune response size controlled by cell 'inheritance'
Australian and Irish researchers have gained previously unachievable insights into how the size of our immune response is controlled, by developing new imaging and computational biology approaches to follow the behaviour of hundreds of cells.
Australian National Health and Medical Research Council, Science Foundation Ireland, European Union Seventh Framework Programme, Australian Postgraduate Award, Edith Moffat Scholarship, Cancer Council Victoria, Victorian Government

Contact: Vanessa S Solomon
communications@wehi.edu.au
61-475-751-811
Walter and Eliza Hall Institute

Public Release: 21-Nov-2016
Nature Communications
BGRF scientists publish seminal paper and announce project to develop biomarkers of aging
The Biogerontology Research Foundation announces the international collaboration on signaling pathway perturbation-based transcriptomic biomarkers of aging. On Nov. 16, scientists at the Biogerontology Research Foundation alongside collaborators from Insilico Medicine Inc., Johns Hopkins University, Albert Einstein College of Medicine, Boston University, Novartis, Nestle and BioTime Inc. announced the publication of their proof of concept experiment demonstrating the utility of a novel approach for analyzing transcriptomic, metabolomic and signalomic data sets, titled iPANDA, in Nature Communications.
Insilico Medicine, Inc., Johns Hopkins University, Albert Einstein College of Medicine, Boston University, Novartis, Nestle, BioTime Inc.

Contact: Charlotte Casebourne
casebourne@bg-rf.org.uk
Biogerontology Research Foundation

Showing releases 201-225 out of 972.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>